Evofem Biosciences Financial Overview
Evofem Biosciences's market cap is currently $1.29M. The company's EPS TTM is $-0.014; its P/E ratio is -0.17; Evofem Biosciences is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
